Skip to main content
. 2022 Mar 5;8:101. doi: 10.1038/s41420-022-00899-5

Fig. 4. rhJAG1 or rhFASLG treatment controls NOTCH signaling activation.

Fig. 4

A rhJAG1 (0.25 ng/mL) or rhFASLG (0.25 ng/mL) treatment promotes NOTCH1 signaling activation. B NOTCH signaling pathway activation analysis by cleavage NOTCH1 expression under rhJAG1 or rhFASLG treatment. C Knockdown of JAG1 or NOTCH1 by shRNA suppresses NOTCH1-ICD cleavage. D The CSC sphere formation assay in JAG1- or NOTCH1-silenced SAS cells. E, F JAG1 Kaplan–Meier plots of OS for the Taiwanese OSCC cohort (E, GSE37991) and the TCGA-HNSC cohort (F).